The extent of ERK1/2 activation for example correlated with aggressiveness of NSCLC tumours and was associated with poor prognosis in patients [61,62] and constitutive EGFR-mediated signaling is usually associated with poor prognosis of many human malignancies [4,5]. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.